Showing results (1741-1750 of 1,823) with videos related to
Sort By:
Pageof 183
Animal Reproduction Science|July 1, 2026
Kit Ligand enhances in vitro oocyte maturation and early embryonic development in sheepQi Yang, Dui Sun, Zhao-Yu Jiang, et al.British Journal of Haematology|March 25, 2017
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized StudyLoretta J Nastoupil, Peter McLaughlin, Lei Feng, et al.Haematologica|November 11, 2021
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomaRaphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, et al.Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.Nature Communications|August 7, 2025
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trialPaolo Strati, Lei Feng, Jason R Westin, et al.Frontiers in Aging Neuroscience|July 26, 2018
Study Protocol for a Randomized Controlled Trial of Choral Singing Intervention to Prevent Cognitive Decline in At-Risk Older Adults Living in the CommunityJasmine Tan, F H Maurine Tsakok, Elisabeth K Ow, et al.Journal for Immunotherapy of Cancer|February 23, 2022
ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of responseLuana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.Blood Advances|August 14, 2019
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysisElisabet E Manasanch, Guangchun Han, Rohit Mathur, et al.Journal of Affective Disorders|October 21, 2017
Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trialTian-Hang Zhou, Wei-Min Dang, Yan-Tao Ma, et al.Pageof 183